The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Zacks Investment Research on MSN
Gilead Sciences (GILD) gains as market dips: What you should know
In the latest trading session, Gilead Sciences (GILD) closed at $146.42, marking a +1.88% move from the previous day. The stock's performance was ahead of the S&P 500's daily loss of 0.48%. Meanwhile, ...
The conversation focused on how a reliable patent system supports the journey from scientific discovery to patient access.
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Cassava Sciences (SAVA) said it will change its name to Filana Therapeutics, reflecting its focus on developing drugs that target the filamin A protein to treat central nervous system disorders. The ...
Lab leasing is showing small signs of improvement in select markets across the U.S., offering a glimmer of hope for landlords stuck in a supply glut for more than two years. But underneath the leasing ...
Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. In a move that will grow its ...
Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The ...
Abbott Laboratories is investigating two separate cybersecurity incidents after confirming unauthorized access to internal legacy Exact Sciences systems in its Cancer Diagnostics business, while also ...
Shares of SELLAS Life Sciences Group (SLS) climbed 12% on Friday, snapping a two-session losing streak. The late-stage clinical biopharmaceutical company is developing cancer therapeutics, including ...
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corporation (NASDAQ: EXAS) (“Exact Sciences”), a leading provider of cancer screening and diagnostic tests, today announced that its stockholders voted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results